Kidder Stephen W Sells 1,627 Shares of Procter & Gamble Co (NYSE:PG)

Share on StockTwits

Kidder Stephen W lowered its position in shares of Procter & Gamble Co (NYSE:PG) by 2.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 72,662 shares of the company’s stock after selling 1,627 shares during the period. Procter & Gamble accounts for 3.3% of Kidder Stephen W’s holdings, making the stock its 9th biggest holding. Kidder Stephen W’s holdings in Procter & Gamble were worth $9,076,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Lucia Wealth Services LLC acquired a new stake in shares of Procter & Gamble in the third quarter valued at about $29,000. Belmont Capital LLC purchased a new stake in Procter & Gamble during the fourth quarter worth about $34,000. Selective Wealth Management Inc. purchased a new stake in Procter & Gamble during the third quarter worth about $35,000. Princeton Global Asset Management LLC boosted its holdings in Procter & Gamble by 51.4% during the second quarter. Princeton Global Asset Management LLC now owns 442 shares of the company’s stock worth $48,000 after buying an additional 150 shares in the last quarter. Finally, Ironwood Financial llc increased its holdings in Procter & Gamble by 27.3% in the third quarter. Ironwood Financial llc now owns 480 shares of the company’s stock valued at $60,000 after buying an additional 103 shares in the last quarter. Institutional investors own 62.74% of the company’s stock.

PG has been the subject of a number of research analyst reports. Wells Fargo & Co increased their target price on shares of Procter & Gamble from $135.00 to $136.00 and gave the company an “outperform” rating in a report on Wednesday, October 23rd. Macquarie boosted their price target on Procter & Gamble from $132.00 to $138.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 23rd. TheStreet upgraded Procter & Gamble from a “c+” rating to a “b+” rating in a report on Tuesday, October 22nd. UBS Group lifted their price objective on Procter & Gamble from $122.00 to $126.00 and gave the stock a “neutral” rating in a report on Wednesday, October 23rd. Finally, Goldman Sachs Group reaffirmed a “buy” rating and set a $136.00 price objective on shares of Procter & Gamble in a report on Wednesday, October 23rd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and seven have given a buy rating to the stock. Procter & Gamble has a consensus rating of “Hold” and a consensus target price of $119.07.

In other news, CEO Steven D. Bishop sold 41,165 shares of the firm’s stock in a transaction on Wednesday, October 23rd. The stock was sold at an average price of $123.36, for a total transaction of $5,078,114.40. Following the sale, the chief executive officer now owns 45,176 shares in the company, valued at $5,572,911.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Ma. Fatima Francisco sold 1,729 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $122.00, for a total value of $210,938.00. Following the sale, the chief executive officer now owns 6,856 shares in the company, valued at approximately $836,432. The disclosure for this sale can be found here. Insiders sold a total of 1,288,513 shares of company stock valued at $159,734,252 in the last three months. 1.75% of the stock is currently owned by corporate insiders.

PG stock opened at $125.96 on Thursday. The stock’s 50 day moving average price is $124.20 and its 200 day moving average price is $120.41. The firm has a market cap of $310.95 billion, a P/E ratio of 27.87, a PEG ratio of 3.38 and a beta of 0.40. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.54 and a current ratio of 0.72. Procter & Gamble Co has a 1 year low of $89.08 and a 1 year high of $126.60.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Tuesday, October 22nd. The company reported $1.37 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.24 by $0.13. Procter & Gamble had a return on equity of 25.07% and a net margin of 6.24%. The company had revenue of $17.80 billion during the quarter, compared to analysts’ expectations of $17.43 billion. During the same period in the previous year, the firm posted $1.12 earnings per share. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. On average, research analysts predict that Procter & Gamble Co will post 4.94 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a dividend of $0.7459 per share. This represents a $2.98 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date of this dividend is Thursday, January 23rd. Procter & Gamble’s dividend payout ratio is presently 65.93%.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

See Also: What is an overbought condition?

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.